Live Biotherapeutic Products, Microbiome Therapeutics
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
118
NCT05053165
A Study to Assess the Safety and Tolerability of LB-P6 and LB-P8 in Healthy Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 4, 2022
Completion: Jun 29, 2022
NCT06699121
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
Phase: Phase 2
Start: Mar 31, 2025
Completion: Feb 28, 2029
Loading map...